This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Debaprasad Jana: Innovator in Asthma Treatment
Introduction
Debaprasad Jana is a notable inventor based in Kolkata, India. He has made significant contributions to the field of medical science, particularly in the treatment of respiratory diseases. His innovative approach has led to the development of a unique method for treating bronchial asthma and chronic obstructive pulmonary disease (COPD).
Latest Patents
Debaprasad Jana holds a patent for a method that involves administering an effective dose of carbazole derivatives or their salts to patients suffering from asthma and COPD. This method is designed to enhance the treatment efficacy for these chronic conditions. The patent also discusses the structural formula of compounds that act as phosphodiesterase-4 (PDE-4) enzyme inhibitors, which are crucial for treating asthma and related diseases. Additionally, the patent outlines both herbal and chemical routes for isolating and preparing these compounds, showcasing a comprehensive approach to innovation in this field.
Career Highlights
Debaprasad Jana is affiliated with the Council of Scientific & Industrial Research, where he continues to engage in groundbreaking research. His work is characterized by a commitment to improving patient outcomes through innovative treatment methods. His dedication to scientific advancement is evident in his patent and ongoing research efforts.
Collaborations
Debaprasad has collaborated with notable colleagues such as Sibabrata Mukhopadhyay and Mumu Chakraborty. These collaborations have further enriched his research and contributed to the development of effective treatment methodologies.
Conclusion
Debaprasad Jana's contributions to the treatment of bronchial asthma and COPD highlight his role as an innovator in the medical field. His patent reflects a significant advancement in respiratory treatment, showcasing his commitment to improving health outcomes for patients.
